Literature DB >> 33540037

Powder flow from an intermediate bulk container - Discharge predictions and experimental evaluation.

Håkan Wikström1, Johan Remmelgas1, Sara Solin2, Mariagrazia Marucci1, Niklas Sandler2, Catherine Boissier1, Pirjo Tajarobi3.   

Abstract

Powders are usually dispensed, blended, and transferred between different manufacturing steps in so-called Intermediate Bulk Containers (IBCs), and discharge from an IBC plays a critical role in the ability to manufacture high-quality tablets. To better understand IBC discharge, the flow behavior of selected excipients was comprehensively characterized using a number of techniques including the Hausner ratio/Carr's index, Erweka flow test, FlowPro flow test, shear test and wall friction test as well as FT4 powder rheometer experiments. Jenike's hopper design methodology was then used to predict the minimum non-arching outlet diameter and the mode of flow. Furthermore, the discharge rate from an IBC was predicted using a simple model that takes into account gravity and aerodynamic drag. The predictions were experimentally verified by measuring the discharge rate from a 20 L IBC using five commonly-used excipients. The small-scale Erweka flow test provided the best prediction of the full-scale IBC discharge experiment. Furthermore, a simple model that relied only on the particle size of the material and the diameter of the discharge opening was found to predict the IBC discharge rate remarkably well.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hopper design; Intermediate bulk container (IBC); Pharmaceutical excipients; Powder flow properties

Mesh:

Substances:

Year:  2021        PMID: 33540037     DOI: 10.1016/j.ijpharm.2021.120309

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  1 in total

Review 1.  Direct Compaction Drug Product Process Modeling.

Authors:  Alexander Russell; John Strong; Sean Garner; William Ketterhagen; Michelle Long; Maxx Capece
Journal:  AAPS PharmSciTech       Date:  2022-01-31       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.